DelMar Pharmaceuticals, Inc. Financial Ratios — DMPWW Stock

Profitability (USD)

	2010 Y	2011 Y	2012 Y	2013 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	06/30/2010	06/30/2011	06/30/2012	12/31/2013	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	06/30/2023

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-119.94	-302.43	-383.78	-126.13	-198.51	-113.29	-148.65	-144.85	-261.67	-464.75	-153.68	-147.03
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Profit Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	-0.14	2.53	8.82	1.48	0.89	0.1	7.71	9.8	2.41
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2010 Y	2011 Y	2012 Y	2013 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	06/30/2010	06/30/2011	06/30/2012	12/31/2013	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	06/30/2023

Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/EBITDA	- -	- -	- -	-0.04	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Debt/EBITDA	7.98	0.17	0.09	0.61	0.37	0.99	0.79	0.54	0.44	0.29	0.49	0.52	0.1
Total Debt/EBIT	- -	- -	- -	-0.04	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Debt/EBIT	7.98	0.17	0.09	0.61	0.37	0.99	0.79	0.53	0.44	0.29	0.49	0.52	0.1
EBITDA to Interest Expense	- -	- -	- -	-784.91	-2,259.52	- -	- -	- -	- -	- -	-828.46	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	-784.91	-2,259.52	- -	- -	- -	- -	- -	-828.77	- -	- -
EBIT to Interest Expense	- -	- -	- -	-784.91	-2,259.52	- -	- -	- -	- -	- -	-829.69	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	0.83	-306.39	-2,991.03	-366.61	-722.35	-507.04	-519.58	-741.2	-1,500.39	-2,372.7	-821.03	-855	-3,804.3
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	-1.75	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	- -	6.31	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/Equity (%)	- -	- -	- -	-33.3	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/Capital (%)	- -	- -	- -	-1.75	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/Total Assets (%)	- -	- -	- -	6.31	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Debt to Equity	-101.48	-53.25	21.9	472.44	213.57	-126.72	-100.11	-109.88	-189.01	-909.51	-99.58	-99.87	-209.99
Net Debt/Capital (%)	100.83	14.81	3.24	19.62	8.74	19.36	15.96	11.49	6.27	3.55	9.87	8.69	1.08
EBITDA	- -	- -	- -	-6	-5	-6	-8	-11	-8	-8	-22	-23	-15
EBITDA-CapEx	- -	- -	- -	-6	-5	-6	-8	-11	-8	-8	-22	-23	-15
Operating Income (Loss)	- -	- -	- -	-6	-5	-6	-8	-11	-8	-8	-22	-23	-15

Liquidity (USD)

API ChatGPT

	2010 Y	2011 Y	2012 Y	2013 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	06/30/2010	06/30/2011	06/30/2012	12/31/2013	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	06/30/2023

Cash Ratio	68.35	- -	0.18	16.58	2.06	9.81	5.05	3.64	1.8	0.89	3.79	2.95	0.5
Current Ratio	68.35	- -	0.18	17.31	3.02	10.07	6.03	4.3	1.94	1.07	4.24	3.32	1.06
Quick Ratio	68.35	- -	0.18	16.63	2.09	9.84	5.11	4.3	1.94	1.03	4.06	3.32	0.71
CFO/Avg Current Liab	- -	-118.98	-2.28	-42.55	-6.99	-6.95	-8.3	-6.69	-3.41	-3.34	-6.91	-6.02	-3.36
Common Equity/Total Assets	0.83	-306.39	-2,991.03	-366.61	-722.35	-507.04	-519.58	-741.2	-1,500.39	-2,372.7	-821.03	-855	-3,804.3
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	-1.75	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	- -	6.31	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/Equity (%)	- -	- -	- -	-33.3	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/Capital (%)	- -	- -	- -	-1.75	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/Total Assets (%)	- -	- -	- -	6.31	- -	- -	- -	- -	- -	- -	- -	- -	- -
CFO/Total Liabilities	-756.13	- -	-114.03	-107.47	-113.43	-343.74	-601.81	-600.8	-305.71	-296.37	-636.73	-491.02	-365.3
CFO/CapEx	- -	- -	- -	- -	- -	-306.99	-382.66	-778.78	- -	- -	-2,357.5	- -	-51.14
Altman's Z-Score	0.59	- -	-85.17	-8.82	-15.37	-9.31	-9.8	-14.73	-27.37	-42.33	-15.96	-15.97	-65.48

Working Capital (USD)

API ChatGPT

	2010 Y	2011 Y	2012 Y	2013 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	06/30/2010	06/30/2011	06/30/2012	12/31/2013	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	06/30/2023

Accounts Receivable Turnover

- -

Days Sales Outstanding

- -

Inventory Turnover

- -

Days Inventory Outstanding

- -

Accounts Payable Turnover

- -

Accounts Payable Turnover Days

- -

Cash Conversion Cycle

- -

Inventory to Cash Days

- -

Inventories

- -

Raw Materials

- -

Work In Process

- -

Finished Goods

- -

Other Inventory

- -

Enterprise Value (USD)

API ChatGPT

	2010 Y	2011 Y	2012 Y	2013 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	06/30/2010	06/30/2011	06/30/2012	12/31/2013	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	06/30/2023

Market Capitalization	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
- Cash & Cash Equivalents	- -	- -	- -	4	2	6	7	6	4	2	11	12	2
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	7	6	6	5	5	15	13	11
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	- -	- -	-4	-1	- -	- -	- -	1	2	4	1	9
Total Capital	- -	- -	- -	-16	-18	-26	-35	-46	-56	-65	-96	-124	-141
Total Debt/Capital (%)	- -	- -	- -	-1.75	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt / EV	- -	- -	- -	-0.07	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Enterprise Value	- -	- -	- -	-4	-1	- -	- -	- -	1	2	4	1	9
EV per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM EBITDA	- -	- -	- -	-6	-5	-6	-8	-11	-8	-8	-22	-23	-15
TTM Operating Income	- -	- -	- -	-6	-5	-6	-8	-11	-8	-8	-22	-23	-15
TTM Cash Flow to Firm	- -	- -	- -	-6	-4	-5	-8	-10	-6	-8	-19	-20	-12
TTM Free Cash Flow to Firm	- -	- -	- -	-6	-4	-5	-8	-10	-6	-8	-19	-20	-12

Multiples (USD)

API ChatGPT

	2010 Y	2011 Y	2012 Y	2013 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
As of date	06/30/2010	06/30/2011	06/30/2012	12/31/2013	06/30/2015	06/30/2016	06/30/2017	06/30/2018	06/30/2019	06/30/2020	06/30/2021	06/30/2022	06/30/2023

Price/Free Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	- -	- -	-4	-1	- -	- -	- -	1	2	4	1	9
Low Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.03	- -
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Free Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Free Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Free Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA Average	7.98	0.17	0.09	0.61	0.31	-0.07	0.02	-0.04	-0.15	-0.3	-0.2	-0.03	-0.62
EV/EBITDA High	7.98	0.17	0.09	0.61	0.31	-0.07	0.02	-0.04	-0.15	-0.3	-0.2	-0.03	-0.62
EV/EBITDA Low	7.98	0.17	0.09	0.61	0.31	-0.07	0.02	-0.04	-0.15	-0.3	-0.2	-0.03	-0.62
EV/EBIT Average	7.98	0.17	0.09	0.61	0.31	-0.07	0.02	-0.04	-0.15	-0.3	-0.2	-0.03	-0.62
EV/EBIT High	7.98	0.17	0.09	0.61	0.31	-0.07	0.02	-0.04	-0.15	-0.3	-0.2	-0.03	-0.62
EV/EBIT Low	7.98	0.17	0.09	0.61	0.31	-0.07	0.02	-0.04	-0.15	-0.3	-0.2	-0.03	-0.62
Last Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.05	- -
High Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.1	0.05
Enterprise Value Average	- -	- -	- -	-4	-1	- -	- -	- -	1	2	4	1	9
Enterprise Value High	- -	- -	- -	-4	-1	- -	- -	- -	1	2	4	1	9
Enterprise Value Low	- -	- -	- -	-4	-1	- -	- -	- -	1	2	4	1	9

Shares Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	2
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Revenue per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Income per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Basic EPS, GAAP	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Basic EPS from Cont Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted EPS, GAAP	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted EPS from Cont Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Free Cash Flow per Basic Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash & Equivalents per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Book Value per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Tangible Book Value per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

DelMar Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)